Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Nanostring Tech (NSTG)

Nanostring Tech (NSTG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,067
  • Shares Outstanding, K 48,118
  • Annual Sales, $ 127,260 K
  • Annual Income, $ -159,540 K
  • 60-Month Beta 1.24
  • Price/Sales 0.03
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade NSTG with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.53
  • Most Recent Earnings $-0.78 on 11/06/23
  • Latest Earnings Date 02/27/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.47
  • Number of Estimates 2
  • High Estimate -0.42
  • Low Estimate -0.52
  • Prior Year -0.95
  • Growth Rate Est. (year over year) +50.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0505 +108.51%
on 02/07/24
0.5500 -80.85%
on 02/01/24
-0.2947 (-73.67%)
since 01/12/24
3-Month
0.0505 +108.51%
on 02/07/24
1.4100 -92.53%
on 11/17/23
-0.9847 (-90.34%)
since 11/13/23
52-Week
0.0505 +108.51%
on 02/07/24
11.7750 -99.11%
on 02/16/23
-11.1647 (-99.07%)
since 02/13/23

Most Recent Stories

More News
NanoString: Q3 Earnings Snapshot

NanoString: Q3 Earnings Snapshot

NSTG : 0.1053 (-37.43%)
10x Genomics Comments on Second UPC Preliminary Injunction Decision

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that the European Unified Patent Court ("UPC")...

TXG : 36.89 (+1.77%)
NSTG : 0.1053 (-37.43%)
10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in Europe

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that the European Unified Patent Court ("UPC")...

TXG : 36.89 (+1.77%)
NSTG : 0.1053 (-37.43%)
NanoString: Q2 Earnings Snapshot

NanoString: Q2 Earnings Snapshot

NSTG : 0.1053 (-37.43%)
Helen of Troy and NanoString Technologies Trade Set-ups

Helen of Troy and NanoString Technologies emerge as hot trades after beating expectations and giving solid guidance for the year.

HELE : 114.94 (+1.82%)
NSTG : 0.1053 (-37.43%)
10x Genomics Files Two New Lawsuits Requesting Preliminary Injunctions Against NanoString's CosMx Products

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it filed new patent litigation against...

TXG : 36.89 (+1.77%)
NSTG : 0.1053 (-37.43%)
Why Shares of NanoString Technologies Are Falling Thursday

The company lost a patent ruling in Germany to life sciences competitor 10x Genomics.

NSTG : 0.1053 (-37.43%)
TXG : 36.89 (+1.77%)
10x Genomics Wins Permanent Injunction Against NanoString's CosMx Products

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has won an injunction in its patent...

TXG : 36.89 (+1.77%)
NSTG : 0.1053 (-37.43%)
NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates

NanoString (NSTG) delivered earnings and revenue surprises of -22.22% and 8.89%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

NSTG : 0.1053 (-37.43%)
EYE : 21.96 (+0.60%)
NanoString: Q1 Earnings Snapshot

NanoString: Q1 Earnings Snapshot

NSTG : 0.1053 (-37.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

NanoString Technologies, Inc. is engaged in the development, manufacture and sale of life science tools. It provides nCounter Analysis System which supports research and development of clinical applications from basic discovery to the development of future molecular diagnostic tests on a single platform....

See More

Key Turning Points

3rd Resistance Point 0.1669
2nd Resistance Point 0.1534
1st Resistance Point 0.1294
Last Price 0.1053
1st Support Level 0.0919
2nd Support Level 0.0784
3rd Support Level 0.0544

See More

52-Week High 11.7750
Fibonacci 61.8% 7.2962
Fibonacci 50% 5.9127
Fibonacci 38.2% 4.5293
Last Price 0.1053
52-Week Low 0.0505

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar